About the Meeting
Antibiotic Resistance (‘ABR’) has featured heavily in the news, and has been a particular concern of the nation’s Chief Medical Officer. ABR has the potential to wipe out the future mortality/longevity improvements we might otherwise reasonably expect from general medical/lifestyle advances. In January 2017 the IFoA set up a working party to model the likely impact of ABR. In this session, members of the working party will present their findings (including plausible future scenarios and mortality/morbidity impacts), and describe the model produced by the working party (with associated UK parameterisation).
- Nicola Oliver, Mortality and Longevity Consultant, Medical Intelligence (UK) Ltd.
- Ross Hamilton, Pensions Consultant, Willis Towers Watson
Tickets available here
(VIRTUAL) IFRS 17 (6-7.30PM)
An IFRS 17 presentation on latest market insight based on real implementation examples.
Zoom (Virtual event)
SIAS Annual Dinner 2021
SIAS looks forward to seeing you at the 2021 Annual Dinner!